最新发布

比利时Rainbow Crops完成970万欧元种子轮融资,加速AI多重基因编辑技术平台落地

大农化网报道:近日,比利时农业科技企业 Rainbow Crops 专注通过复杂农艺性状基因改造培育优质作物品种,该公司宣布完成 970 万欧元种子轮融资。本次融资超额认购,资金将用于升级企业依托人工…

AI Discovers Potential Antimicrobial “Prionin” Peptides

Prions are best known for their role in rare, fatal neurodegenerative diseases. But a new study by researchers at the University of Pennsylvania suggests that proteins in this family may also conceal molecular fragments that can kill bacteria, including drug-resistant strains.

拜耳领投、农业AI基础设施公司Leaf Agriculture 获1300万美元融资

大农化网报道:近日,农业数据基础设施公司 Leaf Agriculture 宣布完成 1300万美元B轮融资。本轮融资由拜耳旗下影响力投资部门 Leaps by Bayer 与多家产业战略投…

巴斯夫新型杀菌剂flufenoxadiazam获FRAC新作用机制认定,列入Group 56

大农化网报道:巴斯夫农业解决方案部门旗下新型杀菌剂活性成分Adapzo® Active(通用名:flufenoxadiazam)日前获得杀菌剂抗性行动委员会(FRAC)的全新作用机制认定,被正式列入新设立的″FRAC Group 56″。该…

The food system needs a rewiring, not a reinvention, Anterra Capital says after $100m raise

“The key in our space is not to focus on creating new categories but focus on the system itself and rewire it,&#82…

Ag Tech Leaders Urge Practical AI Adoption As Industry Focus Shifts From Hype To Measurable Results

Ag Tech leaders are calling for a more practical approach to artificial intelligence adoption in agriculture, arguing that the technology’s greatest value lies not in replacing people but in solving specific business challenges, improving productivity, and helping farmers make better use of data.

2026超级厄尔尼诺:正在逼近的气候冲击与全球农业的应对

世界农化网中文网报道:今年6月11日,美国国家海洋和大气管理局(NOAA)气候预测中心正式发布厄尔尼诺预警(El Niño Advisory)——官方措辞是"厄尔尼诺已经到来"。这不是一个普通的年份性气候通报。同期发布的概率评估显示,此次事件在2026年11月至2027年1月期间演变为"极强"等级的概率高达63%,届时其强度将"跻身1950年以来有仪器记录历史的前列"。欧洲中期天气预报中心(ECMWF)的集合预报中位数更为激进:预计Niño 3.4区域海表温度异常将在今年12月触及+3℃,部分情景甚至超过+4℃。

Bionyra launches with $165m, France’s largest biotech Series A

The oversubscribed Series A of $165 million (~€143 million) was co-led by two strong VCs in the European biotech space, Sofinnova Partners (which, less than a year ago, also co-founded the company) and Jeito Capital. Other participants in the funding are Arkin Bio, Sanofi Ventures, Sixty Degree Capital, Vives Partners, and Apollo Health Ventures.

AbbVie to Acquire Apogee Therapeutics for $10.9B

SAN DIEGO — AbbVie has agreed to acquire Apogee Therapeutics for $10.9 billion, the companies said today, in a deal designed to bolster the buyer’s pipeline with an atopic dermatitis (AD) candidate set to advance to Phase III trials during the second half of this year, and being positioned as a potential challenger to a top-selling drug.

明德立达纳米杀菌剂——纳米明安®在厄瓜多尔上市,高效防控马铃薯晚疫病

马铃薯晚疫病是马铃薯生产中危害最严重的病害之一,对马铃薯产量和品质构成了重大威胁。近日,纳米杀菌剂纳米明安®在厄瓜多尔全新上市,为当地马铃薯种植者更高效地防控晚疫病提供了新的解决方案。 直击种植痛点,科学破解田间难题 马铃薯晚疫病由致病疫霉…